Lipid signaling could shake up the biotech world

11/29/2011 | Seeking Alpha

Drugmakers are increasingly turning to lipidomics to combat diseases, according to this article. Companies that have focused on energy capacity and structure could shift priorities to a third lipid function, lipid signaling.

View Full Article in:

Seeking Alpha

Published in Brief: